11/14/2024
4:46 PM | Apogee Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
10:16 AM | Apogee Therapeutics (Subject)
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
11/14/2024
9:18 AM | Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/12/2024
6:15 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
6:05 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:01 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
7:02 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/06/2024
10:39 AM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
6:59 PM | ACCESS INDUSTRIES MANAGEMENT, LLC (Filed by)
Apogee Therapeutics (Subject)
| Form SC 13G/A | |
10/24/2024
7:10 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | Apogee Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/04/2024
7:01 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
7:02 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
9:05 AM | Apogee Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
10/02/2024
3:20 PM | Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
1:34 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
7:02 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
7:03 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
12:35 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
7:05 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:29 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:25 PM | Apogee Therapeutics (Filer)
| Form S-3ASR | |
08/12/2024
6:00 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
5:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:05 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
7:05 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
12:18 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2024
7:01 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
7:01 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
12:39 PM | Apogee Therapeutics (Subject)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
12:13 PM | Apogee Therapeutics (Subject)
Dambkowski Carl (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
7:12 PM | Apogee Therapeutics (Issuer)
JONES WILLIAM A JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:00 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:01 PM | Apogee Therapeutics (Issuer)
Gottesdiener Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:02 PM | Apogee Therapeutics (Issuer)
Shah Nimish P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:03 PM | Apogee Therapeutics (Issuer)
Fox Jennifer A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:04 PM | Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:05 PM | Apogee Therapeutics (Issuer)
McKenna Mark C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
7:05 PM | Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/30/2024
7:07 PM | Apogee Therapeutics (Issuer)
Bollinger Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:35 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
5 Stocks that could triple in a week (Ad) Robinhood traders have piled $78 billion into this market...
Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here. Click here to pay just $5 for a full year of Stealth Trades |
05/28/2024
6:36 AM | Apogee Therapeutics (Filer)
| Form DEFA14A | |
05/15/2024
3:39 PM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:10 AM | Apogee Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:26 AM | Apogee Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/13/2024
6:05 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:15 PM | Apogee Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:16 PM | Apogee Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:18 PM | Apogee Therapeutics (Filer)
| Form ARS | |
04/01/2024
4:42 PM | Apogee Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
04/01/2024
4:44 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:30 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
5:01 AM | Apogee Therapeutics (Filer)
| Form 424B4 | |
03/07/2024
11:15 PM | Apogee Therapeutics (Filer)
| Form EFFECT | |
03/07/2024
5:27 PM | Apogee Therapeutics (Filer)
| Form S-1MEF | |
03/05/2024
7:15 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:11 AM | Apogee Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
5:15 AM | Apogee Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:35 AM | Apogee Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Apogee Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
3:30 PM | Apogee Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
01/31/2024
3:31 PM | Apogee Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest II L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Fairmount Healthcare Fund L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
7:00 PM | Apogee Therapeutics (Issuer)
HENDERSON MICHAEL THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
7:00 PM | Apogee Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
7:01 PM | Apogee Therapeutics (Issuer)
Dambkowski Carl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
